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Background: Drug-eluting stents(DES) have reduced in-stent restenosis(ISR) and target legion revascularization(TLR). However, diabetes 
mellitus(DM) is still major concern of ISR and TLR in the early phase after DES implantation. Previous reports have shown the advantage of paclitaxel 
compared to limus-derivative drugs for the treatment of diabetes. Thus, we investigated whether there is stent-specifc prevalence of angioscopic 
characteristics in the patients with DM having paclitaxel-eluting stent(PES) or everolimus-eluting stent(EES).
Methods: Serial angiography and angioscopy was performed in the first 12 months(average 8.8±3.2 months) in 100 stents of 63 patients who 
received PES(n=33) or EES(n=30). Fourteen diabetic patients were received PES and ten diabetic patients were received EES. Then, the prevalence of 
angioscopic neointimal coverage, yellow grade, in-stent thrombus and TLR was compared between PES and EES, and between DM and non DM.
Results: The overall prevalene of TLR was 7.3% and the prevalence between PES and EES was not significant (8.3% vs. 6.3%:p=0.283). The TLR 
in patients with DM was higher than those without DM, however it was not significant(11.1% vs. 4.4%:p=0.130). The prevalence of TLR compared 
between PES and EES in the patients with DM became comparable (10.7 % vs.12.5%:p=0.446). The overall average of neointima grade was 1.62. 
The neointima grade in the patients received PES was higher than that in the patients received EES(1.8 vs.1.4:p=0.031). And the prevalence of 
neointima grade in the patients with DM was significantly higher in the patients with PES than those with EES (2.3 vs.1.3:p=0.016).
Conclusions: hese data suggested that EES showed greater neointimal suppression in angioscopic findings than PES in diabetic patients and EES 
is more likely to reduce ISR and TLR in the patients with DM than PES, however it is insufficient. The larger trial is need to prove the efficacy.
